https://new.immunopaedia.com/wp-content/uploads/2025/03/Emmanuel-Adamolekun.jpeg
Emmanuel Adamolekun is a Medical Laboratory Scientist based in Nigeria, he currently works as a research assistant at Helix Biogen Research institute under the supervision of Dr Elijah Oladipo (Clinical Immunology and Microbiology specialist).
Emmanuel earned his Medical Laboratory Science degree in 2018 from Ladoke Akintola University of Technology, Ogbomosho, Nigeria. He has worked as a Medical Laboratory Scientist at the Department of Medical Laboratory Services, University of Medical Science Teaching Hospital, Akure
Emmanuel has developed research interests in vaccinology specifically the in field of Immunoinformatics, where bioinformatic approaches are used in designing vaccines.
We would love to hear more about your ongoing research. What projects are you currently working on and how do they impact the field?
Helix Biogen institute where I work is an institute established to act as a driving force for innovation in the field of Biomedical Sciences. We are committed to the advancement of Life Science with the use of technology. In achieving this, we are deploying creative innovations that can be adopted by the healthcare system and biomedical industry in form of diagnostic kits, therapeutic peptides, monoclonal antibodies, and vaccine for infectious diseases.
So, I am currently exploring Leishmania Thoi-specific antioxidant protein to design to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach. Check us out: https://www.helixbiogeninstitute.org
There are many areas of science and immunology is quite broad and complex. What inspired you to choose this branch of science over others?
My inspiration to pursue immunology stems from its pivotal role in public health, particularly in vaccine development. Witnessing the devastating impact of infectious diseases in Africa, where vaccine access is limited, highlighted the urgency of advancing immunological research. Immunology’s potential to develop life-saving interventions, especially in underserved regions, drives my passion. The need for local vaccine manufacturing in Africa further motivated me to focus on immunology, as it offers a way to improve health security on the continent. By contributing to this field, I aim to play a part in reducing global health disparities.
What specifically stood out about Immunopaedia that made you want to be an ambassador?
What stood out about Immunopaedia is its free and open-access platform, making immunological knowledge accessible to everyone. Its use of clinical case studies to educate on immunology aligns with my passion for applied learning. Additionally, Immunopaedia offers excellent networking opportunities with experts in the field, which is crucial for advancing my career goals in Genomics of Infectious Diseases and vaccine development for neglected tropical diseases.
Based on your own experience, what one piece of advice would you give someone who wants to study/research immunology?
Immunology is a platform for translational research where one can develop health interventions that can impact the world in ways you that you cannot imagine. Just like what vaccines doing today to save lives. Give it your best shot!
If not immunology, then what? Which other field(s) would have benefited from your contribution and why?
If not Immunology, I would go for law, as we are still born into a society where people are denied their human rights daily. It is sad. I would defend the rights of others so that everyone around me is treated equally.
What has been a moment of unexpected joy or surprise in your scientific career that has stayed with you?
The most unexpected joy for me was in 2019, when the abstract from my undergraduate thesis “The impact of Antiretroviral therapy on the blood coagulation on HIV-known patients attending a HIV clinic in one of South-western cities in Nigeria” was accepted by two international conferences, ICASA 2019 and 2019 Nigeria Centre for Disease Control/National Field Epidemiology Training Programme (NFETP) Conference. Seeing my abstract being accepted was extremely exciting as a young graduate with little research experience. I did have to choose one of the conferences to present my paper at, I chose the NCDC/NFETP Conference, where I presented my research findings to experts and public health professionals. I was both nervous and excited! I left the conference with a new worldview – that success knows no age, education status or sex if you give in your best. That has been my compass in my career development.
To have a better understanding of where your input lies in immunology, may we please have your most recent publications?
To read more about what we do at Helix Biogen Institute: https://www.helixbiogeninstitute.org/publications
